Genetically engineered human acetylcholinesterase

Hermon Soreq; Zakut Haim

doi:10.1016/S0734-9750(97)87541-6

Genetically engineered human acetylcholinesterase

Hermon Soreq^*
, Zakut Haim

^*Corresponding author for this work

Alexander Silberman Institute of Life Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

Genetically engineered human acetylcholinesterase and antibodies that define the protein are described. These composition may be used in pharmaceutical preparations for treatment and prophylaxis of organo-phosphorous compound poisoning or post-operative apnea. Also described are human cholinesterase DNA probes which may be employed for diagnosing progressing ovarian carcinomas and hemocytopoietic disorders.

Original language	English
Pages (from-to)	672
Number of pages	1
Journal	Biotechnology Advances
Volume	15
Issue number	3-4
DOIs	https://doi.org/10.1016/S0734-9750(97)87541-6
State	Published - 1997

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0734-9750(97)87541-6

Cite this

@article{0685d005e3e5461181dd46baf941592a,

title = "Genetically engineered human acetylcholinesterase",

abstract = "Genetically engineered human acetylcholinesterase and antibodies that define the protein are described. These composition may be used in pharmaceutical preparations for treatment and prophylaxis of organo-phosphorous compound poisoning or post-operative apnea. Also described are human cholinesterase DNA probes which may be employed for diagnosing progressing ovarian carcinomas and hemocytopoietic disorders.",

author = "Hermon Soreq and Zakut Haim",

year = "1997",

doi = "10.1016/S0734-9750(97)87541-6",

language = "אנגלית",

volume = "15",

pages = "672",

journal = "Biotechnology Advances",

issn = "0734-9750",

publisher = "Elsevier Inc.",

number = "3-4",

}

TY - JOUR

T1 - Genetically engineered human acetylcholinesterase

AU - Soreq, Hermon

AU - Haim, Zakut

PY - 1997

Y1 - 1997

N2 - Genetically engineered human acetylcholinesterase and antibodies that define the protein are described. These composition may be used in pharmaceutical preparations for treatment and prophylaxis of organo-phosphorous compound poisoning or post-operative apnea. Also described are human cholinesterase DNA probes which may be employed for diagnosing progressing ovarian carcinomas and hemocytopoietic disorders.

AB - Genetically engineered human acetylcholinesterase and antibodies that define the protein are described. These composition may be used in pharmaceutical preparations for treatment and prophylaxis of organo-phosphorous compound poisoning or post-operative apnea. Also described are human cholinesterase DNA probes which may be employed for diagnosing progressing ovarian carcinomas and hemocytopoietic disorders.

UR - https://www.scopus.com/pages/publications/0030717088

U2 - 10.1016/S0734-9750(97)87541-6

DO - 10.1016/S0734-9750(97)87541-6

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:0030717088

SN - 0734-9750

VL - 15

SP - 672

JO - Biotechnology Advances

JF - Biotechnology Advances

IS - 3-4

ER -

Genetically engineered human acetylcholinesterase

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this